MediConcepts was founded with the aim to provide the optimized solutions for medical device design development and manufacturing to a wide range of customers whether they are innovators who need a compliant product development process and collaboration; or projects seeking for a reliable high quality mass production with complete traceability.
Early projects that MediConcepts encountered include redeveloping a two hand operated intra-ocular lens disposable case to an one hand operated casing in late 90’s; and a minimal invasive tissue retrieval system originated from a UK surgeon who is also a pioneer in minimal access surgery in early 2000’s. The design briefs were simply a hand-sketched drawing faxed to us and we delivered a complete design and production in less than 6 months. Since then, our philosophy has been focusing on “design by surgeon for surgeons” medical devices.
The range of products that we now cover are very broad. “Think Medical” is our believe and “Redefine the medical device Contract Manufacturing Experience” is what we want to offer to our customers. Eventually, we want to position MC to be the ideal CM.
Contact
Address 7A-D Hong Kong Industrial Building, 444-452 Des Voeux Road West, Hong Kong
Tel: +852 2838 0300
Website: http://www.mediconcepts.com/
Email: marketing@mediconcepts.com
Haematological oncologist Dr Raymond Liang, gives his take on the adoption and challenges of CAR-T therapy in Hong Kong, the necessity of collaboration with mainland China for patient referrals and…
Hong Kong Exchanges and Clearing Limited (HKEX) chief executive Nicolas Aguzin has stepped down after a term fraught with upheaval. Having survived COVID-19 isolation, under Aguzin HKEX was confronted with…
Although well-established as Asia’s leading financial services and trading hub, Hong Kong has never truly been globally competitive in the innovation and technology space, despite piecemeal initiatives to bolster its…
While much of PharmaBoardroom’s recent report on Hong Kong and the Greater Bay Area looks at how Hong Kong is attempting to position itself as a development and financing hub…
Hong Kong provides some of the best and most efficient healthcare in Asia, with Hong Kongers living to over 85 on average (compared to 83 in Singapore and 78 in…
A decade on from its launch, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) initiative has made some significant wins but remains some way from fulfilling the vision of a fully…
2018 marked a significant milestone in Hong Kong’s journey towards creating a vibrant biotech market for investors which allows Asian innovation to receive the funding it needs to progress. It…
Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons, Professor Dennis Lo, is aiming to change the…
Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within the global clinical research…
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on its established areas of finance and…
Novartis, one of the world’s largest biopharma companies, has secured approval and market access for two of its most advanced cell and gene treatments in Hong Kong. The firm’s territory…
Generative Artificial Intelligence (AI) has grabbed a lot of media attention in recent months following the launch of chatbot ChatGPT, but the pharmaceutical industry has long been trying – and…
See our Cookie Privacy Policy Here
